Synapsoft logo
AI Insights from Disclosures
Searching...
ANTEROGEN CO., LTD. 065660
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
ANTEROGEN CO., LTD. is a bio venture company that develops and produces therapeutics based on stem cells, which have the ability to differentiate into cells of various tissues, among cell therapies, a type of biopharmaceutical. The company began by establishing a research institute in Boston, United States in 2000, and was the first in South Korea to begin product development research using bone marrow-derived stem cells and adipose-derived stem cells; based on its long experience and accumulated technology, in January 2012 it succeeded in commercializing Cupistem, the world's first adipose-derived stem cell therapy for Crohn's fistula, a rare disease, by obtaining marketing approval.
Representative Director 이성구, 김미형(각자대표)
Founded March 16, 2000
Corporation Type KOSDAQ
Industry Classification Other specialized wholesale
Corporate number 11011-1909906
Business number 108-81-21711
Phone Number 02-2104-0391
Fax Number 02-2104-0393
Company Address 130 Digital-ro, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant